IIPLA News
Thursday, May 6, 2021

Germany Opposes US-Supported WTO Proposal to Waive COVID-19 Vaccine Patents

Berlin asserts intellectual property protections are not obstructing vaccine production despite global calls for a temporary waiver

IIPLA News Deskanonymous access0 articles left this week
Germany Opposes US-Supported WTO Proposal to Waive COVID-19 Vaccine Patents
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

Germany has formally rejected the US-backed initiative at the World Trade Organization to temporarily waive intellectual property rights on COVID-19 vaccines. The German government emphasized that patents are not the bottleneck in vaccine manufacturing, highlighting production capacity and quality standards as primary…
Share This Article
Ready-to-post copy includes the article link.

Germany Opposes US-Supported WTO Proposal to Waive COVID-19 Vaccine Patents Germany has formally rejected the US-backed initiative at the World Trade Organization to temporarily waive intellectual property rights on COVID-19 vaccines. The German government emphasized that patents are not the bo... Read the full IIPLA article: https://iipla.org/news/germany-opposes-us-supported-wto-proposal-to-waive-covid-19-vaccine-patents

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Broadfield Strengthens London Office with Two New Partners in Private Wealth and IP Law

Broadfield has appointed Sarah Sarwar and Ash von Schwan as partners in its London office, bolstering its private wealth and intellectual property capabilities. Sarwar brings expertise in estate planning and cross-border tax for high-net-worth clients, while von Schwan focuses on IP and technology transactions across…

Monday, June 15, 2026